NYSE:EW

Edwards Lifesciences Stock News

etoro logo Buy EW
*Your capital is at risk
$86.00
-1.66 (-1.89%)
At Close: Jun 03, 2026
Investors with an interest in Medical - Instruments stocks have likely encountered both Integer (ITGR) and Edwards Lifesciences (EW). But which of these two stocks is more attractive to value investor

Why Edwards Lifesciences Stock Plummeted Today

06:15pm, Thursday, 26'th Oct 2023
The maker of medical devices posted third-quarter results that broadly met analyst expectations. That wasn't the reason for the resulting investor sell-off, however.
Edwards Lifesciences (EW) TMTT performance benefits from the accelerated adoption of the differentiated PASCAL precision platform in the third quarter.
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include PepsiCo (PEP), The J.M.
Edwards Lifesciences Corporation (NYSE:EW ) Q3 2023 Earnings Conference Call October 25, 2023 5:00 PM ET Company Participants Mark Wilterding - SVP, IR and Treasurer Bernard Zovighian - CEO Scott Ulle
While the top- and bottom-line numbers for Edwards Lifesciences (EW) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key me
Edwards Lifesciences (EW) came out with quarterly earnings of $0.59 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.61 per share a year ago.
Edwards Lifesciences Corp on Wednesday reported a 12% rise in third-quarter sales, helped by strong demand for the company's artificial heart valves and other devices.
We have narrowed our search to five large-cap stocks that are set to declare third-quarter earnings results this week. These are: EW, VICI, VMC, GLPI, MBLY.
Outside the United States, Edwards Lifesciences (EW) TAVR sales growth will likely be driven by broad-based adoption of the SAPIEN platform.
Medical Product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how EW, PODD, DXCM and IQV are poised ahead of their earnings release.
Edwards Lifesciences (EW) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
IRVINE, Calif. , Oct. 18, 2023 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended September 30, 2023 after the market closes on Wednesday, Oc
September-quarter earnings among medical-device makers may prove better than expected in the age of weight-loss drugs.
Investors remain optimistic about Edward Lifesciences (EW) on the strength of the Critical Care business and TAVR sales.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE